Manual or device input, referral network and rewards all aimed at improving healthcare, and access to the professional network of your choice
A healthcare information storage sized for the individuals and pets, easy to use, low cost while preserving ability to share with professionals
Track your pet, and their activity, health signals, reminders, call the vet, order meds and supplies, share the data with a click!
True Nature Holding, Inc. is a publicly held, development stage company who’s driven to create shareholder value by developing and acquiring innovative technologies that provide higher quality care at a lower delivery costs for both the human and pet markets.
During 2016 and 2017 we focused on Pharmacy and Compound Pharmacy Operations. We learned that the best growth opportunity going forward was to facilitate better Health Care through technology.
Going forward, TNTY has shifted focus toward providing technology that benefits both Human and Veterinarian care using Telehealth and Telemedicine Solutions. We are building healthcare applications that focus on:
Telemedicine is the remote delivery of health care services and clinical information using telecommunications technology. “The rise of the internet age brought with it profound changes for the practice of telemedicine. The proliferation of smart devices, capable of high-quality video transmission, opened up the possibility of delivering remote healthcare to patients in their homes, workplaces or assisted living facilities as an alternative to in-person visits for both primary and specialty care.”*
We believe there is an opportunity to develop telemedicine solutions for both the Human and Vet Healthcare market that:
According to Veterinary business specialist Ed Blach, DVM, MBA:*:
Learn about our Board of Directors, Management Team and our Shareholder Information
We routinely gather timely information about our markets from creditible third parties, research firms, and even our peer group companies. Click here to read more.
Direct-to-consumer (DTC) telemedicine is growing at an ever-expanding rate due to new phone, computer, app technology and patient demand. Now, patients can quickly assess healthcare providers for phone or video visits via their personal devices. For hospitals and providers, the big draw with virtual visits is the potential savings involved in replacing physician office visits and ER visits
Upon Completion of the Transaction, Henry Schein Shareholders Will Own Approximately 63%and Vets First Choice Shareholders Will Own Approximately 37% of the New Company; Henry Schein Expects to Receive Between $1.0-1.25 Billion in Cash on a Tax-Free Basis
Included in the acquisition are exclusive licenses to a portfolio of genetic disease tests patented in the U.S., Australia and many countries in Europe, and an extensive biobank of more than 150,000 samples collected over 20 years representing various canine eye diseases. Moving forward these samples will be used to discover new genetic health markers for dogs.
The American Telemedicine Association provides this comprehensive guide to the application in today's markets.
The US Health and Human Services Department has a dedicated healthcare IT staff. Read how these see the chance to impact lives using technology.
Market research report with industry analysis on “Global Telemedicine Market-Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2021” is made available by Orbis Research.
Telehealth has arisen as one of the greatest opportunities and challenges facing medicine in this digital age. Using telemedicine in the delivery of veterinary medical services offers benefits for animal owners, patients and the profession. However, veterinary services must be provided with professionalism and adhering to the same standard of care, whether delivered in person or through electronic means.
Telehealth, spurred by the rise of digital communications technologies, presents both opportunities and challenges for healthcare providers, including veterinarians and their staff. Understanding key definitions is important as you decide whether and how to implement telemedicine in your practice.
In a competitive market, money flows toward the best opportunity. Which suggests that veterinary hospitals offer a better return than other types of businesses. April 2017.
We have a team of dedicated professionals who understand their goal is to respect the interests all shareholders while maximizing the market opportunity.
President and Interim CEO
Jay Morton, age 51, was the founder of Local Pet Rx in 2014, where he developed a pet compounding e-prescribing application that was used by pharmacies and vets. In addition to starting multiple healthcare companies he also served as HIT Business Segment Manager for McKesson, CEO of ScanMD and Vice President of Endoscopy Sales at Dessert Medical Services, Inc., an affiliate of Fuji Films. Mr. Morton has a BA from Florida State University in 1990 and an MBA from University of Phoenix in 2009.
Chief Operations Officer
Louis Deluca, age 59, formerly served as VP of Operations for Mondetta US, Inc., an online apparel designer and retailer, where he built all operations for the U.S. based division, he served as the COO of The Ivory Company, a multichannel home décor retailer where he built all operations, he Founded and sold Marietta Sign Company, he served The Home Depot for 25 years in many capacities helping them grow from 4 stores to over 2200, leaving as the Director of Inventory Planning and Sourcing.
Chairman and Chief Financial Officer
Dr. Jordan Balencic, D.O., age 31, is a physician of Internal Medicine and serial entrepreneur, and currently serves the U.S Department of Veterans Affairs as a Primary Care Physician. He has founded businesses in the marketing, telehealth and healthcare product development areas. He has extensive consulting and healthcare advisory experience. He completed his IM Residency training at PSU, obtained his Medical Doctoral degree at LECOM, and earned his B.S. in Biology from Gannon University.
Director and Pharmacy Industry Executive
James Czirr, age 62, sits on the Board of Galectin Therapeutics Inc(NASDAQ:GALT), which he co-founded. He co-founded 10X Fund, L.P. and is a managing member of 10X Capital Management LLC. He was instrumental in the early stage development of Safe Science Inc., a developer of anti-cancer drugs; served as CEO of Minerva Biotechnologies Corporation, a developer of nano-particle bio chips; and was a consultant to Metalline Mining Company Inc., now Silver Bull Resources, Inc., (AMEX: SVBL).
Phillip Giordano, age 58, is the owner of a compounding pharmacy in Boca Raton, Florida which specializes in both veterinary medicine as well as specialized human medications. He is a licensed pharmacist, and has advised the Company since the formation of Newco4pharmacy, LLC, which was acquired by the Company in 2015. Previously as director of Pharmacy Services in Pompano Beach, Florida, he was responsible for sales and distribution of all internet related prescription sales in 16 states
True Nature Holding, Inc.
1355 Peachtree Street, Suite 1150
Atlanta, GA 30309
Phone: (844) 383 - TNTY(8689)
Investor Inquiries: email@example.com
Legal Counsel: Sheppard Mullin Richter & Hampton LLP
Andrea Cataneo, Partner, ACataneo@sheppardmullin.com
30 Rockefeller Plaza, New York, NY 10112 (212) 634-3096
Accounting/Auditing Firm: M&K CPAS, PLLC
63 North Sam Houston Pkwy E, Houston, TX 77060 (832) 242-9950
Investment Banker: Dawson James Securities, Carlo Corzine firstname.lastname@example.org
1 North Federal Hwy., 5th Floor, Boca Raton, FL 33432 (866) 928-0928
Please contact us directly with any questions, comments, or scheduling inquiries you may have.
Feel free to fax any documents to (404) 876-3338
1355 Peachtree Street, Suite 1150, Atlanta, GA 30309, US
Monday - Friday: 9AM–5PM
Saturday - Sunday: Closed
This presentation contains certain forward-looking information about us that is intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts.
Words such as “guidance,” “expect,” “will,” “may,” “anticipate,” “plan,” “estimate,” “project,” “intend,” “should,” “can,” “likely,” “could,” “outlook” and similar expressions are intended to identify forward-looking statements. These statements include statements about our plans, strategies and prospects.
Forward-looking statements are not guarantees of performance. These statements are based upon the current beliefs and expectations of our management and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot assure you that the expectations will prove to be correct.
Among the factors that could cause actual results to differ materially from the expectations expressed in the forward-looking statements are:
he impact on us of our substantial indebtedness, including on our ability to obtain financing on acceptable terms to finance our operations and growth strategy and to operate within the limitations imposed by financing arrangements;
Additionally, new risk factors emerge from time to time and it is not possible for us to predict all such risk factors, or to assess the impact such risk factors might have on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. You should not place undue reliance on any forward -looking statements on our website, which speak only as of the date they were placed on the website. Except to the extent required by applicable law or regulation, we undertake no obligation to update or publish revised forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events